MXPA03010205A - Derivados de acido oxalico. - Google Patents

Derivados de acido oxalico.

Info

Publication number
MXPA03010205A
MXPA03010205A MXPA03010205A MXPA03010205A MXPA03010205A MX PA03010205 A MXPA03010205 A MX PA03010205A MX PA03010205 A MXPA03010205 A MX PA03010205A MX PA03010205 A MXPA03010205 A MX PA03010205A MX PA03010205 A MXPA03010205 A MX PA03010205A
Authority
MX
Mexico
Prior art keywords
oxalic acid
acid derivatives
tumours
prophylaxis
inhibitors
Prior art date
Application number
MXPA03010205A
Other languages
English (en)
Inventor
Werner Mederski
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA03010205A publication Critical patent/MXPA03010205A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se describen compuestos novedosos de la formula (I) en la cual R1, R2, R3, R4, X y Z tienen los valores definidos en la reivindicacion 1, son inhibidores del factor de la coagulacion Xa y que se pueden emplear en la profilaxis y/o terapia de trastornos tromboembolicos y en el tratamiento de tumores.
MXPA03010205A 2001-04-10 2002-03-18 Derivados de acido oxalico. MXPA03010205A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10117823A DE10117823A1 (de) 2001-04-10 2001-04-10 Oxalsäurederivate
PCT/EP2002/002963 WO2002083630A1 (en) 2001-04-10 2002-03-18 Oxalic acid derivatives

Publications (1)

Publication Number Publication Date
MXPA03010205A true MXPA03010205A (es) 2004-03-10

Family

ID=7681049

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010205A MXPA03010205A (es) 2001-04-10 2002-03-18 Derivados de acido oxalico.

Country Status (13)

Country Link
US (1) US20040220411A1 (es)
EP (1) EP1377543A1 (es)
CN (1) CN1514823A (es)
CA (1) CA2445538A1 (es)
CZ (1) CZ20032935A3 (es)
DE (1) DE10117823A1 (es)
HU (1) HUP0303733A2 (es)
MX (1) MXPA03010205A (es)
PL (1) PL364901A1 (es)
RU (1) RU2003132539A (es)
SK (1) SK13382003A3 (es)
WO (1) WO2002083630A1 (es)
ZA (1) ZA200308669B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1558606A4 (en) * 2002-10-02 2008-05-07 Bristol Myers Squibb Co DIAMINOALKYL CONTAINING LACTAM, BETA AMINO ACIDS, ALPHA AMINO ACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
DE10302500A1 (de) 2003-01-23 2004-07-29 Merck Patent Gmbh Carbonsäureamidderivate
JP2006521304A (ja) * 2003-03-24 2006-09-21 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ｒａｆキナーゼ阻害剤として有用なオキサミド誘導体
EP3431464A3 (en) 2003-08-06 2019-07-31 Senomyx Inc. Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
CN1933827B (zh) * 2004-02-27 2011-07-27 默克雪兰诺有限公司 亚甲基酰胺衍生物在制备治疗和/或预防心力衰竭的药物中的用途
JP2008531525A (ja) * 2005-02-24 2008-08-14 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチド製剤を安定化する化合物
US7662824B2 (en) 2005-03-18 2010-02-16 Janssen Pharmaceutica Nv Acylhydrazones as kinase modulators
CA2693396A1 (en) 2007-07-10 2009-01-15 Sanofi-Aventis Malonamide derivatives with antithrombotic activity
RU2015151129A (ru) 2009-10-08 2019-01-15 Санофи Производные фенилоксадиазола в качестве ингибиторов pgds
CN114728917B (zh) * 2019-12-04 2023-12-08 深圳信立泰药业股份有限公司 草酰胺类衍生物、其制备方法及其在医药上的应用
CN112079747B (zh) * 2020-10-20 2022-08-16 浙江工业大学 一种n-苄氧基取代的对称草酰胺类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1183234A1 (en) * 1999-05-24 2002-03-06 Cor Therapeutics, Inc. INHIBITORS OF FACTOR Xa

Also Published As

Publication number Publication date
US20040220411A1 (en) 2004-11-04
ZA200308669B (en) 2005-02-07
WO2002083630A1 (en) 2002-10-24
DE10117823A1 (de) 2002-10-17
PL364901A1 (en) 2004-12-27
CN1514823A (zh) 2004-07-21
RU2003132539A (ru) 2005-04-20
CZ20032935A3 (cs) 2004-01-14
SK13382003A3 (sk) 2004-03-02
CA2445538A1 (en) 2002-10-24
EP1377543A1 (en) 2004-01-07
HUP0303733A2 (hu) 2004-03-01

Similar Documents

Publication Publication Date Title
ZA200306419B (en) Phenyl derivatives.
MY140031A (en) Carbonyl compounds
TW200504012A (en) Ethynylproline derivatives
HK1065033A1 (en) Thiazole compounds useful as inhibitors or proteinkinases
BG108181A (en) Novel spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
NO20045677L (no) Inhibitorer av JAK- og CDK2-proteinkinaser
MXPA03010142A (es) Nuevos derivados de arilheteroalquilamina.
NO20002958L (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
WO2004002477A8 (de) 2-(phenyl)-2h-pyrazol-3-carbonsäure-n-4-(thioxo-heterocyclyl)-phenyl-amid derivate und entsprechende imino-heterocyclyl derivate sowie verwandte verbindungen als inhibitoren der koagulationsfaktoren xa und/oder viia zur behandlung bon thrombosen
AU2003278667A1 (en) Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
MXPA03010205A (es) Derivados de acido oxalico.
SE0302756D0 (sv) Novel Compounds
SE9803773D0 (sv) Compounds
MY134079A (en) Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian-acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors
BR0008608A (pt) Derivados de pirazol-3-ona
MXPA04001121A (es) Derivados de fenilo.
WO2002074735A3 (de) Biurethanderivate
MXPA05007715A (es) Derivados de carboxamida y uso de los mismos como inhibidores del factor xa.
SE0102641D0 (sv) Novel compounds
NO20005435L (no) Bifenylderivater
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina
ATE265423T1 (de) Neue phenylheteroalkylamin-derivate
MY136138A (en) Hexacyclic compounds
SE0102640D0 (sv) Novel compounds
AU2002322396A1 (en) 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists

Legal Events

Date Code Title Description
FA Abandonment or withdrawal